ATS 2024 Final Program

Click on the session title to view the speakers

274

TUESDAY • MAY 21

P93 Patient- and Proxy-reported Outcome Measurement Instruments for the Assessment of Asthma Control: A Content Analysis Overview According to the International Classification of Functioning, Disability, and Health Framework P94 Brazilians’ Perception on Asthma Control: Analysis of Focus Groups Discussions Among Pediatric Population and Caregivers P95 Summarizing the Characteristics of the Instruments to Assess Asthma Control in Children, Adolescents, and Adults: A Systematic Review P96 A Tool to Assess Clinical Diversity in Pediatric Meta-analyses (CDIPM) of Interventions P97 Parental Perspectives: Pediatric Asthma and the Health Impacts of Climate Change P98 The Role of Standardizing Asthma Management and Education for Patients With Uncontrolled Asthma Symptoms P99 School Staff Education Program to Enhance Care for Students With Asthma in Communities With High Prevalence P100 Impact of a Severe Asthma Virtual Home Visit on Medication Adherence P101 Implementation of a Clinical Standard Work Pathway in Patients With Congenital Diaphragmatic Hernia Leads to Decreased Readmission Rate P102 Reasons Driving Teen and Young Adult E-cigarette Vapers to Switch to or Add in Combustible Tobacco Cigarettes P103 Preoperative Vaping Screening in Pediatric Patients P104 Engaging Youth in Pollution and Lung Health Monitoring in Washington Heights, New York City: A Pilot Study P105 Prenatal Delta-9-tetrahydrocannabinol Exposure Adversely Impacts Lung Development, Function, and Volume in Rhesus Macaque Offspring P106 Role of Race and the Childhood Opportunity Index in Predicting Lung Function Outcomes Among Adolescents and Adults Born Premature

BASIC • CLINICAL • TRANSLATIONAL THEMATIC POSTER SESSION

C67 SCIENCE AND BEDSIDE BACTERIAL PNEUMONIA 9:15 a.m. - 4:15 p.m. Viewing: Posters will be on display for entire session Discussion: 11:30-12:30 Discussionwith facilitators, authors, andattendees 12:30-1:15 Authorswill beby their posters for individual discussionwithattendees P1350 Features of Community Acquired Pneumonia and Implicated Microbial Pathogens Before and After the COVID-19 Pandemic P1351 Anti-inflammatory Roles of Type I Interferon Signaling in the Lung P1352 IGF1R Plays a Protective Role in Pneumococcal Pneumonia P1353 Inhibition of Pseudomonas Aeruginosa-Induced Ferroptosis Protects Host Lung Function During Acute and Chronic Murine Lung Infections P1354 The Effect of Corticosteroid Use on the Mortality of Community Acquired Pneumonia: A Systematic Review and Meta-analysis of Randomized Controlled Trials P1355 Anti-bacterial Efficiency of a Novel Phage Cocktail Against Clinical Pseudomonas Aeruginosa P1356 Establishing an In Vivo Galleria Mellonella Model for Studying Pseudomonas Aeruginosa Bacteriophage Interactions P1357 Comparing Outcomes Among Pneumonia Prediction Models in Elderly Patients: A Single Center Validation Study P1358 Cell-specific CD40 Expression During Development of Lung-resident Heterotypic Immunity P1359 Enterobacteriaceae Species Drive Inflammation in Intra-abdominal Sepsis in Mice and Humans P1360 Long Read 16S rRNA Sequencing Identifies a Link Between Sputum Microbiome Dysbiosis and Disease Severity in Chronic Obstructive Pulmonary Disease San Diego Convention Center Area L (Hall H, Ground Level)

ATS 2024 Conference Program • San Diego, CA